Key facts
- SpendRule’s last known valuation is $8.5M (Feb 2026).
- It has raised $2.5M; the latest was Seed Round ($2.5M) in Feb 2026.
- Notable investors include Zeal Capital Partners, Abundant Venture Partners, Diatonic Healthcare, MemorialCare Innovation Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for SpendRule
- ·The full record, as it builds
Funding rounds
No funding rounds for SpendRule are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SpendRule
Developer of a contract intelligence platform intended to prevent overpayments, recover savings, and ensure vendor compliance by automating service contract compliance and invoice validation. The company uses artificial intelligence to turn complex service contracts into structured validation rules, enabling healthcare systems to gain real-time visibility into purchased service contracts.
- Sector
- Healthcare
- HQ
- Prosper, TX, United States
- Founded
- 2025
- Website
- spendrule.com/
- Ownership
- Privately Held (backing)
SpendRule doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SpendRule shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SpendRule in its N-PORT filings yet. We sweep new filings monthly.